EditorialAnn Med Surg (Lond)2024
FDA endorses NALIRIFOX for metastatic pancreatic adenocarcinoma: an editorial.
- Journal
- Ann Med Surg (Lond)
- Published
- 10 September 2024
- Citations
- 3
- Type
- Editorial
- License
- cc by
- Full text
- Open access, reuse-licensed (cc by)
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Its licensed text is not loaded here yet, so most questions will be declined.
Try